CME Form 144: Proposed sale of 1,000 common shares

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting a proposed sale of 1,000 common shares tied to CME with an aggregate value listed as $320,000.00 and an execution date of 03/06/2026.

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting a proposed sale of 1,000 common shares tied to CME with an aggregate value listed as $320,000.00 and an execution date of 03/06/2026.

The filing also lists restricted stock lots of 748 shares with grant date 06/25/2024 and 252 shares with grant date 06/26/2023.

Insights

Compliance & Insider Transactions Specialist

Form 144 notifies a brokered proposed sale of 1,000 CME common shares.

The filing lists a proposed sale quantity of 1,000 common shares and an aggregate amount of $320,000.00, with an execution date of 03/06/2026. The broker is identified as Morgan Stanley Smith Barney LLC.

The record also lists restricted stock grants of 748 and 252 shares with grant dates 06/25/2024 and 06/26/2023. This is a regulatory notice of intent to sell; actual execution and proceeds depend on subsequent transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for CME report?

It reports a proposed sale of 1,000 common shares valued at $320,000. The form names Morgan Stanley Smith Barney LLC as the broker and shows an execution date of 03/06/2026.

Who is the broker listed on the CME Form 144?

The filing lists Morgan Stanley Smith Barney LLC as the broker. The broker's address is shown as 1 New York Plaza, 8th Floor, New York, NY, in the filing excerpt.

Does the Form 144 show any restricted stock lots for CME?

Yes — the filing lists restricted stock lots of 748 and 252 shares. The 748-share grant is dated 06/25/2024 and the 252-share grant is dated 06/26/2023.

Are proceeds from the sale specified in the Form 144?

An aggregate amount of $320,000.00 is listed alongside the 1,000-share sale. The filing pairs that figure with the execution date 03/06/2026 in the excerpt provided.

Does the filing confirm the sale has occurred for CME shares?

No — Form 144 is a notice of proposed sale, not a confirmation of execution. Actual sale execution and final proceeds depend on subsequent brokerage transactions and reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 04:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001643475
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CME GROUP INC.
SEC File Number	001-31553
Address of Issuer	20 South Wacker Drive Chicago ILLINOIS 60606
Phone	(312) 930-1000
Name of Person for Whose Account the Securities are To Be Sold	ELIZABETH ANNE COOK TRUST U/A DTD 01/08/1999
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	320000.00	358622331	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2024	Restricted Stock	Issuer			748	06/25/2024	Not Applicable
Common	06/26/2023	Restricted Stock	Issuer			252	06/06/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth A Cook
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)